Drug Trial Radar · NCT07845487
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
204
Planned (sponsor's estimate)
Start
Aug 28, 2026
Primary completion
Oct 2027
Study completion Jun 2028
Sponsor
- Lead sponsor
- Palisade BioIndustry
- Sponsor type
- Industry
- First posted
- Sep 29, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The ASCENTRA-UC study is a phase 2 study testing PALI-2108 in patients with moderate to severe ulcerative colitis. Doses of drug will be compared against a placebo to see how well it works, how safe it is, and how the body responds to it.
Conditions
- Ulcerative Colitis (UC)
- Severe Ulcerative Colitis
- Moderate Ulcerative Colitis
Interventions
PALI-2108Drug
Oral Dose
PALI-2108Drug
Oral Dose
PlaceboDrug
Oral Dose
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of participants with clinical remission using the 3-component modified Mayo Score (mMS) at Week 12.Time frame: Week 12
Locations
114 sites in 12 countries. Site status is shown where the registry gives one.
Site US-022
Sun City, Arizona · Recruiting
Site US-018
San Diego, California · Recruiting
Site US-028
Bristol, Connecticut · Recruiting
Site US-026
Orlando, Florida · Recruiting
Site US-005
Des Plaines, Illinois · Recruiting
Site US-007
Glenview, Illinois · Recruiting
Site US-020
Gurnee, Illinois · Recruiting
Site US-008
Baton Rouge, Louisiana · Recruiting
Site US-011
Mandeville, Louisiana · Recruiting
Site US-010
Tupelo, Mississippi · Recruiting
Site US-006
St Louis, Missouri · Recruiting
Site US-014
Clifton, New Jersey · Recruiting
Site US-002
Albany, New York · Recruiting
Site US-016
Rochester, New York · Recruiting
Site US-025
Brunswick, Ohio · Recruiting
Site US-023
Dayton, Ohio · Recruiting
Site US-027
Westlake, Ohio · Recruiting
Site US-019
Providence, Rhode Island · Recruiting
Site US-003
Cordova, Tennessee · Recruiting
Site US-024
Garland, Texas · Recruiting
Site US-009
Georgetown, Texas · Recruiting
Site US-030
Houston, Texas · Recruiting
Site US-015
Lubbock, Texas · Recruiting
Site US-017
Mansfield, Texas · Recruiting
Site US-001
Southlake, Texas · Recruiting
Site US-004
Tyler, Texas · Recruiting
Site US-013
Richmond, Virginia · Recruiting
Site US-021
Bellevue, Washington · Recruiting
Site US-029
Tacoma, Washington · Recruiting
Site US-012
Milwaukee, Wisconsin · Recruiting
Site CA-005
Calgary, Alberta, Canada · Not yet recruiting
Site CA-004
Edmonton, Alberta, Canada · Not yet recruiting
Site CA-006
Greater Sudbury, Ontario, Canada · Not yet recruiting
Site CA-003
London, Ontario, Canada · Not yet recruiting
Site CA-002
Scarborough Village, Ontario, Canada · Not yet recruiting
Site CA-007
Montreal, Quebec, Canada · Not yet recruiting
Site CA-001
Montreal, Quebec, Canada · Not yet recruiting
Site CZ-005
Brno, Czechia · Not yet recruiting
Site CZ-002
Brno, Czechia · Not yet recruiting
Site CZ-008
Havířov, Czechia · Not yet recruiting
Showing 40 of 114 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.